Skip to content
About
Acer Management
Board of Directors
Key Strategic Consultants
Scientific Advisory Board
Pipeline
EDSIVO™ for vEDS
ACER-001 for UCD
ACER-001 for MSUD
Osanetant
Patients & Physicians
Patient Organizations
Publications
Medical Information Request
Vascular Ehlers-Danlos Syndrome (vEDS)
Urea Cycle Disorders (UCDs)
Maple Syrup Urine Disease (MSUD)
Induced Vasomotor Symptoms (iVMS)
Expanded Access
Investor Relations
Investor FAQs
Analyst Coverage
Corporate Governance
SEC Filings
Stock Information
Press Releases
Events & Presentations
Contact Us
About
Pipeline
Investor Relations
Publications
Contact Us
Investor FAQs
Analyst Coverage
Corporate Governance
Stock Information
Events & Presentations
About
Pipeline
Investor Relations
Publications
Contact Us
Press Releases
Investor Relations
Filter by Year
2019
2018
2017
2016
2015
2014
QUICK
NAV
MENU
MENU
About
Acer Management
Board of Directors
Key Strategic Consultants
Scientific Advisory Board
Pipeline
EDSIVO™ for vEDS
ACER-001 for UCD
ACER-001 for MSUD
Osanetant
Patients & Physicians
Patient Organizations
Publications
Medical Information Request
Vascular Ehlers-Danlos Syndrome (vEDS)
Urea Cycle Disorders (UCDs)
Maple Syrup Urine Disease (MSUD)
Induced Vasomotor Symptoms (iVMS)
Expanded Access
Investor Relations
Investor FAQs
Analyst Coverage
Corporate Governance
SEC Filings
Stock Information
Press Releases
Events & Presentations
Contact Us
We use cookies to ensure that we give you the best experience on our website. By using our site, you consent to cookies.
Learn more.
Ok
